Early Experience Treating Vestibular Migraine With Small Molecule CGRP Antagonists

Gepants are well-tolerated by patients and are promising agents for the treatment of vestibular migraine.

Authors

Jeffrey D. Sharon (ORCID: https://orcid.org/0000-0003-4892-5064)
Evan J. Patel
Kali Koziol

Institutions

University of California, San Francisco (US)

Publication Details

Journal: Otolaryngology
Published: 2026-03-03
DOI: https://doi.org/10.1002/ohn.70196
Primary Topic: Vestibular and auditory disorders
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Early Experience Treating Vestibular Migraine With Small Molecule CGRP Antagonists

Jeffrey D. Sharon, Evan J. Patel, Kali Koziol

Mar 3, 2026

Otolaryngology

Vestibular and auditory disorders

article

Early Experience Treating Vestibular Migraine With Small Molecule CGRP Antagonists

Jeffrey D. Sharon, Evan J. Patel, Kali Koziol

March 3, 2026article en

Abstract

Gepants are well-tolerated by patients and are promising agents for the treatment of vestibular migraine.

Otolaryngology

University of California, San Francisco (US)

Good health and well-being

Openalex Percentile: Top 48%

Vestibular and auditory disorders

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Early Experience Treating Vestibular Migraine With Small Molecule CGRP Antagonists — Jeffrey D. Sharon, Evan J. Patel, et al. · Otolaryngology (2026) | TGRS Research Map | TGRS